BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12090443)

  • 1. Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine.
    Leonard P; Halley A; Browne S
    Ir Med J; 2002 Apr; 95(4):119-20. PubMed ID: 12090443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipidemia and schizophrenia].
    Wetterling T; Schneider B; Weber B
    Psychiatr Prax; 2007 Jul; 34(5):223-9. PubMed ID: 17160750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 23():39-44. PubMed ID: 11603884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
    Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ
    Parkinsonism Relat Disord; 2004 Oct; 10(7):439-41. PubMed ID: 15465403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-induced severe mixed hyperlipidemia: a case report.
    Ahmed M; Griffin D; O'Toole R; McDonald C
    Gen Hosp Psychiatry; 2009; 31(1):93-6. PubMed ID: 19134516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P; Dimitri E; Tessier S; Légaré N
    J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
    J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-associated elevation in serum triglycerides.
    Gaulin BD; Markowitz JS; Caley CF; Nesbitt LA; Dufresne RL
    Am J Psychiatry; 1999 Aug; 156(8):1270-2. PubMed ID: 10450273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review.
    Bitter R; Demler TL; Opler L
    J Psychiatr Pract; 2008 Sep; 14(5):265-70. PubMed ID: 18832957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia and diabetes mellitus: not an improbable combination].
    Cohen D; Gispen-de Wied CC
    Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.
    Zhang X; Sun Z; Zhang D; Zheng L; Li J; Liu S; Xu C; Li J; Hu D; Sun Y
    Heart Lung; 2009; 38(1):17-24. PubMed ID: 19150527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid dose-dependent effect of clozapine on a schizophrenic patient's lipid profile.
    Chiang HL; Liu CC; Hwang TJ
    J Psychopharmacol; 2009 Jun; 23(4):465-7. PubMed ID: 18562410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients.
    Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC
    Diabetes Metab Res Rev; 2005; 21(2):183-8. PubMed ID: 15386811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.